Imaging Study Maps 16 Million Cells, Uncovers Early Type 1 Diabetes Damage

3 articles · Updated · Nature.com · Jul 2

Using imaging mass cytometry on 88 donor pancreata, researchers found type 1 diabetes changes begin before symptoms, with beta cells losing IAPP in multiple-autoantibody-positive cases and showing broader functional decline as disease advances.
The 16 million-cell dataset also identified pro-inflammatory macrophages and exhausted-like PD1+ TIM3+ T cells clustering at islet edges and in inflamed islets, pointing to early immune interactions that may help drive progression.
Beta cells in inflamed islets showed rising MHC-I first, then MHC-II and interferon-response markers during T-cell infiltration, while the study did not detect higher levels of three measured endoplasmic-reticulum stress markers versus controls.
Age patterns suggested younger donors had more B-cell-rich, TLS-like infiltrates and other immune features linked to more severe disease, while the authors said the atlas highlights potentially actionable targets before extensive beta-cell loss.

Sources

Nature.com1d ago

Imaging Mass Cytometry Reveals Early Type 1 Diabetes β-Cell Dysfunction and Immune Interactions in Human Pancreata

Hoodline1d ago

Gainesville Lab Catches Diabetes In The Act With Pancreas Mega‑Map

UF Health News1d ago

UF Health researchers map early immune attack in Type 1 diabetes - UF Health

With a key stress theory now in doubt, what is the true initial trigger for β-cell failure in Type 1 Diabetes?

Can cancer immunotherapies be safely repurposed to halt the autoimmune attack in the earliest stages of Type 1 Diabetes?

Unveiling the Hidden Stages of Type 1 Diabetes: Cellular Mapping, Early Detection, and Personalized Therapies

Overview

A groundbreaking study published in 2026 used advanced imaging mass cytometry and spatial transcriptomics to create detailed cellular atlases of the human pancreas, offering an unprecedented look at the cellular changes during the onset of Type 1 Diabetes (T1D). This research, highlighted by experts as crucial for understanding how and why T1D develops, mapped cells and islets at high resolution. The resulting atlases reveal early indicators of the disease and provide new insights into the complex pancreatic environment before clinical symptoms appear, setting the stage for improved early detection and the development of targeted therapies.

...